Hyderabad: Bharat Biotech International Limited (BBIL), the Indian vaccines and bio-therapeutics manufacturer, on Wednesday announced that its rotavirus oral vaccine ROTAVAC has been introduced to immunise its children from the life-threatening diarrhoeal disease that affects millions of children worldwide. Taking to Twitter, Bharat Biotech said, “Rotavac was introduced into the... The post appeared first on .

Hyderabad Feb 24 PTI Though the scientific achievement with regards to tackling COVID-19 pandemic is commendable there was lack of global coordination on some of the issue and several countries did not abide by the framework put out by the World Health Organisation Soumya Swaminathan Chief Scientist of WHO said on Thursday Speaking at a panel discussion as part of BioAsia 2022 she said though over 70 per cent of people in high income countries vaccinate against less than 10 per cent of people in African countries even as there was ease on vaccine supply side globally I think while the scientific achievements have been absolutely outstanding such as vaccines in less than a year and a lot of progress on diagnostics self-test kits and antivirals technology and the genomic surveillance which has allowed us to track the evolution of the virus but where we fell short was a global coordination the harmonised way of approaching the pandemic she said Referring to the reaction to travel restrictions on South Africa when a new variant of COVID-19 was found she said those kind of restrictions will not help during pandemics The WHO chief scientist further said though the world has passed over the phase of acute supply shortage that was seen throughout 2021 the challenge is going to be massive as there are many countries which are not able to mount the kind of massive vaccination programmes Even though WHO put out a framework for equitable healthcare access and share them equitably countries did not play by that and each country was trying to look after itself which has resulted in over 70 per cent of people in high income countries vaccinate against less than 10 per cent of people in African countries she said According to her countries are now discussing a treaty for a pandemic agreement for binding principles or agreements on how countries must act She also said the WHO is working on scenarios where variant-proof vaccines are developed and suggested that there is a need for a distributed manufacturing network across the globe Amitabh Kant CEO of NITI Aayog who also participated in the panel discussion opined that the government needs to incentivise the research and development and also sectors such as biopharma in a big way to help India transition from a low value high-volume player to a high value high volume player in the global pharma market We are examining ways to strengthen the system for and push for greater industry-academia collaborations There is a need to promote innovation global partnerships and knowledge sharing amongst our scientific community he said Krishna Ella chairman and managing director of Bharat Biotech International Limited said some of the regulatory processes should be simplified in order to act fast on product development PTI GDK GDK SS SS

New Delhi [India], January 25 (ANI): Chief Executive Officer of the Serum Institute of India (SII) Adar Poonawalla on Tuesday congratulated the deserving individuals who will receive the Padma awards this year.

New Delhi [India], January 25 (ANI): Bharat Biotech Chairman Krishna Ella and co-founder Suchitra Ella will be conferred with Padma Bhushan on the 73rd Republic Day.

New Delhi [India], December 18 (ANI): Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech along with Suchitra Ella Joint Managing Director, Bharat Biotech, met Professor, Dr Tran Van Thuan, Deputy Minister of Health, Government of the Socialist Republic of Vietnam, in New Delhi.

Hyderabad (Telangana) [India], November 12 (ANI): Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech's Covaxin.

New Delhi [India], October 23(ANI): Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India (DCGI) for the COVID-19 vaccine for children.